Fusion Pharmaceuticals, Inc. vs. UNIVERSITÄT HEIDELBERG et al.

Explore the PTAB proceeding IPR2023-00551 filed by Fusion Pharmaceuticals, Inc. on 2023-02-13. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2023-00551

Filing Date

2023-02-13

Accorded Filing Date

2023-02-13

Institution Decision Date

2023-08-15

Last Modified Date

2024-03-12

Proceeding Type

IPR

Termination Date

2024-03-12

Trial Status

Terminated-Settled

Parties & Counsel

Petitioner

Fusion Pharmaceuticals, Inc.

Represented By

Cipriano, Linneaet al

Patent Owner / Respondent

UNIVERSITÄT HEIDELBERG et al.

Represented By

Hasan, S. Artet al

Tribunal & Venue

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Patent Information

1 Patent Involved

Respondent Application Number 16470104

Respondent Patent Number 10980901

External Links

Espacenet

Google Patents

Respondent Inventor Alfred MORGENSTERN et al

Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Address and Attorney/Agent Information

48 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name Lewis Roca Rothgerber Christie LLP

Customer Number 23363

Address PO BOX 29001, Glendale, CA, 91209-9001, UNITED STATES

Attorney / Agent Information

Reg #	Name	Phone
25090	Merl Carson Iii	626-795-9900
29946	Michael Macdermott	626-795-9900
32213	Thomas Daly	626-795-9900
35581	Gregory Lampert	626-795-9900
36408	Gregory Leibold	303-628-9565
37208	David Plumley	626-795-9900
39759	Constantinos Marantidis	626-795-9900
41057	Syed Hasan	626-795-9900
43693	Jun Young Jeon	626-795-9900
43945	Raymond Tabandeh	626-795-9900
44257	Gary Nelson	626-795-9900
45574	Peter Hsueh	626-795-9900
46083	Josephine Chang	626-795-9900
59469	Jason Martone	949-476-0757
59799	Joshua Chu	949-476-0757
62600	Ryan Swank	626-795-9900
63184	Evan Boetticher	650-687-8435
63787	Yuan Yuan Zhang	626-795-9900
64458	Katherine Quigley	626-795-9900
64743	Daniel Ueno	626-795-9900
65345	Steven Wilson	310-920-3739
66490	Yong Kwun	626-795-9900
67995	Shaun Lee	626-795-9900
68503	Olga Katsnelson	626-795-9900
68986	Dustin Szakalski	626-795-9900
69242	Michael Curry	626-795-9900
69244	Sharon Du	713-632-1400
70811	Abazar Mireshghi	626-795-9900
71165	Kyle Kellar	626-795-9900
71855	David Harrell	303-628-9535
72269	Jennifer White	510-316-1351
72736	Amrita Chakrabarti	626-683-4559
72952	Yao Liu	949-232-9887
73336	Lashanya Nash	626-795-9900
73655	Martin Regehr	626-683-4534
73867	Justin Ehresmann	626-795-9900
74938	John Mihelcic	469-243-3070
75137	Kurt Prange	626-795-9900
75236	Eric Cheong	303-628-9531
75924	Michael Wagner	303-628-9568
76283	Daniel Salgado	303-628-9538
77921	Young Hoon Lim	626-795-9900
78634	Siho Yoo	415-979-6911
78743	Steven French	626-683-4585
78980	Chin Lin Huang	650-687-880
79784	Rachel Hammond	303-357-1185
80367	Lindsay Oaster	303-623-9000
82135	Joshua Trinkler	626-795-9900

Proceeding Documents

123

Termination Decision: Post-DI Settlement TERMINATE

2024-03-12 FILING PARTY: BOARD

Download

Petitioner's Updated Exhibit List NOTICE

2024-03-01 FILING PARTY: PETITIONER

Download

Joint Request that the Parties' Agreements be Treated as Business Confidential Information Pursuant to 35 U.S.C. § 317 and 37 C.F.R. § 42.74 MOTION

2024-03-01 FILING PARTY: PETITIONER

Download

Joint Motion to Terminate Pursuant to 37 C.F.R. §§ 42.72 & 42.74 MOTION

2024-03-01 FILING PARTY: PETITIONER

Download

3004

Exhibit 3004 Exhibit

2024-02-29 FILING PARTY: BOARD

Download

Fusion Pharmaceuticals, Inc. vs. UNIVERSITÄT HEIDELBERG et al.

Proceeding Overview

Parties & Counsel

Petitioner

Fusion Pharmaceuticals, Inc.

Represented By

Patent Owner / Respondent

UNIVERSITÄT HEIDELBERG et al.

Represented By

Tribunal & Venue

Patent Information

Address and Attorney/Agent Information

Power of Attorney & Correspondence

Attorney / Agent Information

Proceeding Documents

Termination Decision: Post-DI Settlement TERMINATE

Petitioner's Updated Exhibit List NOTICE

Joint Request that the Parties' Agreements be Treated as Business Confidential Information Pursuant to 35 U.S.C. § 317 and 37 C.F.R. § 42.74 MOTION

Joint Motion to Terminate Pursuant to 37 C.F.R. §§ 42.72 & 42.74 MOTION

Exhibit 3004 Exhibit

Notice of Joint Stipulation to Modify Due Dates 2 and 3 of the Scheduling Order NOTICE

Petitioner's Objections to Patent Owners' Evidence Submitted with Patent Owners' Response OTHER

Exhibit 2055 Exhibit

Exhibit 2057 Exhibit

Exhibit 2054 Exhibit

Exhibit 2056 Exhibit

Patent Owners' Response Pursuant to 37 C.F.R. 42.120 RESPONSE

Exhibit 2010 Exhibit

Exhibit 2035 Exhibit

Exhibit 2038 Exhibit

Exhibit 2040 Exhibit

Exhibit 2032 Exhibit

Exhibit 2049 Exhibit

Exhibit 2027 Exhibit

Exhibit 2052 Exhibit

Exhibit 2048 Exhibit

Exhibit 2024 Exhibit

Exhibit 2029 Exhibit

Exhibit 2019 Exhibit

Exhibit 2018 Exhibit

Exhibit 2020 Exhibit

Exhibit 2011 Exhibit

Exhibit 2009 Exhibit

Exhibit 2017 Exhibit

Exhibit 2037 Exhibit

Exhibit 2023 Exhibit

Exhibit 2053 Exhibit

Exhibit 2013 Exhibit

Exhibit 2047 Exhibit

Exhibit 2051 Exhibit

Exhibit 2008 Exhibit

Exhibit 2034 Exhibit

Exhibit 2025 Exhibit

Exhibit 2028 Exhibit

Exhibit 2015 Exhibit

Exhibit 2045 Exhibit

Exhibit 2030 Exhibit

Exhibit 2036 Exhibit

Exhibit 2022 Exhibit

Exhibit 2046 Exhibit

Exhibit 2044 Exhibit

Exhibit 2012 Exhibit

Exhibit 2021 Exhibit

Exhibit 2041 Exhibit

Exhibit 2033 Exhibit

Exhibit 2016 Exhibit

Exhibit 2026 Exhibit

Exhibit 2014 Exhibit

Exhibit 2050 Exhibit

Exhibit 2007 Exhibit

Exhibit 2031 Exhibit

Exhibit 2039 Exhibit

Exhibit 2042 Exhibit

Patent Owner’s Amended Notice of Deposition of Dr. Rebecca Abergel NOTICE

Patent Owner's Notice of Deposition of Dr. Rebecca Abergel NOTICE

Notice of Joint Stipulation to Modify Due Dates of Scheduling Order NOTICE

Exhibit 3003 Exhibit

Patent Owner's Updated Mandatory Notice NOTICE

Petitioner's Objections to Patent Owner's Evidence Submitted with Patent Owner's Preliminary Response OTHER

Institution Decision DECISION